Clinical Trials Logo

2nd Line Metastatic Colorectal Cancer clinical trials

View clinical trials related to 2nd Line Metastatic Colorectal Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT02605044 Recruiting - Clinical trials for 2nd Line Metastatic Colorectal Cancer

Study to Compare the Efficacy and Safety of Masitinib in Combination With FOLFIRI to Placebo in Combination With FOLFIRI in Second Line Treatment of Patients With Metastatic Colorectal Cancer

Start date: January 2014
Phase: Phase 3
Study type: Interventional

The objective is to compare the efficacy and safety of masitinib in combination with FOLFIRI ( irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients.